Related Experiment Video

Updated: May 21, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

[Quality of life in patients with coronary artery disease after stem cell therapy]

A S Nemkov, S A Belyĭ, Iu A Nesteruk

    Vestnik Khirurgii Imeni I. I. Grekova
    |June 1, 2012
    PubMed

    Insights

    Autologous bone marrow mononuclear cell therapy improved cardiac function and reduced angina in patients with coronary artery disease unsuitable for revascularization. This regenerative medicine approach showed significant benefits over standard treatment.

    Area of Science:

    • Cardiovascular Medicine
    • Regenerative Medicine
    • Interventional Cardiology

    Context:

    • Patients with distal coronary artery lesions often have limited treatment options.
    • Complete direct myocardial revascularization may not be feasible for all coronary artery disease (CAD) patients.
    • Standard medical therapy can be insufficient for managing symptoms and disease progression in complex CAD.

    Purpose:

    • To evaluate the efficacy of autologous bone marrow mononuclear cell (BM-MNC) administration in patients with distal coronary artery lesions.
    • To compare the outcomes of BM-MNC therapy with standard medical treatment in a control group.
    • To assess the impact of BM-MNC therapy on angina class, exercise tolerance, and myocardial perfusion.

    Summary:

    • A study involved 17 patients receiving autologous bone marrow mononuclear cells (BM-MNCs) for distal coronary lesions, compared to 10 controls on standard therapy.
    • One year post-treatment, the BM-MNC group showed reduced angina, improved exercise capacity (metabolic units), and decreased nitroglycerin use.
    • Quantitative Exercise and Perfusion Scintigraphy (QECT/PECT) revealed enhanced myocardial perfusion in all segments for the BM-MNC group, contrasting with negative dynamics in the control group.

    Impact:

    • Autologous bone marrow mononuclear cell therapy represents a promising regenerative approach for refractory coronary artery disease.
    • This therapy can potentially improve myocardial perfusion and functional status in patients ineligible for conventional revascularization.
    • The findings suggest a significant clinical benefit of cell-based therapy in enhancing cardiac function and quality of life.

    More Related Videos

    Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

    Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

    Published on: January 25, 2019

    Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy11:51

    Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

    Published on: March 1, 2016

    Related Concept Videos

    Stem Cell Therapy for Tissue Regeneration01:21

    Stem Cell Therapy for Tissue Regeneration

    Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
    Types of Stem Cells used in Stem Cell Therapy
    The two main cell types that...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Coronary Artery Disease III: Clinical Manifestations01:30

    Coronary Artery Disease III: Clinical Manifestations

    Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
    Source And Potency Of Stem Cells01:27

    Source And Potency Of Stem Cells

    Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.